The mechanism of inhibition of factor III (thromboplastin) activity by apolipoprotein B-100: Protein-protein interactions

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 5, 1996, Pages 639-647

  Ettelaie, Camille ^a   James, Nicola J ^a   Wilbourn, Barry ^a   Adam, Jacqueline M ^a   Naseem, Khalid M ^a   Bruckdorfer, K Richard ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

apolipoprotein B 100; factor III (thromboplastin); factor VII; factor X; UV spectroscopy

Indexed keywords

APOLIPOPROTEIN B100; THROMBOPLASTIN;

AGAR GEL ELECTROPHORESIS; ARTICLE; BLOOD CLOTTING; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; ULTRAVIOLET SPECTROSCOPY;

EID: 0029940173     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.5.639     Document Type: Article

References (27)

1. Nemerson Y, Pepke D. Tissue factor accelerates the activation of coagulation factor VII: the role of a bifunctional coagulation cofactor. Thromb Res. 1985;51:165-173.
2. Bajaj SP, Harmony JAK, Martinez-Carrion M, Castellino FJ. Human plasma lipoproteins as accelerators of prothrombin activation. J Biol Chem. 1976;251:5233-5236.
3. Nemerson Y. Tissue factor and haemostasis. Blood. 1988;71:1-8.
4. Broze GJ, Miletich JP. Characterization of the inhibition of tissue factor in serum. Blood. 1987;69:150-155.
5. Rao LVM, Rapaport SI. Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation. Blood. 1987;69:645-651.
6. Sandset PM, Warn-Cramer BJ, Rao LVM, Maki SL, Rapaport SI. Deletion of extrinsic pathway inhibitor [EPI] sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: evidence supporting a physiologic role for EPI as a natural anticoagulant. Proc Natl Acad Sci USA. 1991;88:708-712.
7. Kondo S, Kisiel W. Evidence that plasma lipoproteins inhibit the factor VIIa-tissue factor complex by a different mechanism than extrinsic pathway inhibitor. Blood. 1987;70:1947-1954.
8. Howell RM, Ettelaie C. Inhibition of thromboplastin by serum fractions from various species. Biochem Soc Trans. 1989;17:576-577. Abstract.
9. Howell RM, Ettelaie C. The effect of barium sulphate adsorbable proteins on thromboplastin activity. Biochem Soc Trans. 1990;18: 680-681. Abstract.
10. Ettelaie C, Howell RM, Bruckdorfer KR. The effect of lipid per-oxidation and lipolysis on the ability of lipoproteins to influence thromboplastin activity. Biochim Biophys Acta. 1995;1257:25-30.
11. Ettelaie C, Howell RM. The inhibition of thromboplastin by apolipoprotein B and the effect of various lipids. Thromb Res. 1992;68: 175-184.
12. Carson SD. Tissue factor (coagulation factor III) inhibition by apolipoprotein A-II. J Biol Chem. 1987;262:718-721.
13. Kondo S, Noguchi M, Funakoshi T, Fujikawa K, Kisiel W. Inhibition of human factor VII-tissue factor activity by placental anticoagulant protein. Thromb Res. 1987;48:449-459.
14. Sanders ML, Bajaj SP, Zivelin A, Rapaport SI. Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma component. Blood. 1985;66:204-212.
15. Bruckdorfer KR, Ettelaie C. The use of LDL-resembling particle (LDL-r) as a model for the investigation of the effect of oxidation on the behaviour of LDL. Biochem Soc Trans. 1995;23:243. Abstract.
16. Ettelaie C, Howell RM, Bruckdorfer KR. Vitamin E protects the inhibitory effect of low density lipoprotein towards thromboplastin. 35th Meeting of the International Society of Lipid Biochemists; Aberdeen, Scotland; 1994. Abstract.
17. Wilcheck W, Miron T. Immobilization of enzymes and affinity ligands onto agarose via stable and uncharged carbamate linkages. Biochem Int. 1982;4:629-635.
18. Howell RM, Rezvan H. Circular dichroic, infrared and other studies on the protein component of pig brain thromboplastin. Biochem J. 1980;189:209-218.
19. Erlanson-Albertson C, Åkerlund H. Conformational change in pancreatic lipase induced by colipase. FEBS Lett. 1982;144:38-42.
20. Rao CNR. Ultraviolet and Visible Spectroscopy. 2nd ed. London, England: Butterworth; 1967.
21. Goldstein JL, Brown MS, Anderson RG. Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. Annu Rev Cell Biol. 1985;1:1-39.
22. DeLoof H, Rosseneu M, Yang CY, Li WH, Gotto AM, Chan L. Human apolipoprotein B: analysis of internal repeats and homology with other apolipoproteins. J Lipid Res. 1987;28:1455-1465.
23. Chou PY, Fasman GD. Empirical predictions of protein conformation. Annu Rev Biochem. 1978;47:251-276.
24. Gamier J, Osguthorpe DJ, Robson B. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J Mol Biol. 1978;120:97-120.
25. Harlos K, Martin DMA, O'Brien DP, Jones EY, Stuart DI, Polikarpov I, Miller A, Tuddenham EGD, Boys CWG. Crystal structure of the extracellular region of human tissue factor. Nature. 1994;370: 662-666.
26. Aviram M, Presser D. Oxidized low-density lipoprotein reduces plasma coagulation in vitro. Scand J Clin Lab Invest. 1991;51:17-21.
27. 2+-catalysed oxidation of human low density lipoproteins monitored by Fourier transform infrared Spectroscopy. Biochim Biophys Acta. 1987;922:145-154.